Follow
Alba Pérez-Cordón
Alba Pérez-Cordón
Fundació ACE
Verified email at fundacioace.org
Title
Cited by
Cited by
Year
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
8132022
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
1682021
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project
S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ...
Alzheimer's & Dementia 15 (10), 1333-1347, 2019
1322019
New insights on the genetic etiology of Alzheimer’s and related dementia
C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ...
MedRxiv, 2020.10. 01.20200659, 2020
712020
Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
D Sánchez, M Castilla-Marti, O Rodríguez-Gómez, S Valero, A Piferrer, ...
Scientific reports 8 (1), 16345, 2018
582018
The role of verb fluency in the detection of early cognitive impairment in Alzheimer’s disease
M Alegret, M Peretó, A Pérez, S Valero, A Espinosa, G Ortega, ...
Journal of Alzheimer's Disease 62 (2), 611-619, 2018
532018
Visual impairment in aging and cognitive decline: experience in a Memory Clinic
M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ...
Scientific reports 9 (1), 8698, 2019
522019
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ...
Scientific reports 11 (1), 6448, 2021
482021
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ...
Alzheimer's research & therapy 10, 1-12, 2018
442018
The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline
A Sanabria, M Alegret, O Rodriguez-Gomez, S Valero, O Sotolongo-Grau, ...
Scientific Reports 8 (1), 3828, 2018
362018
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy …
S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ...
Alzheimer's & Dementia 14 (5), 634-643, 2018
352018
FACEHBI: A prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols
O Rodriguez-Gomez, A Sanabria, A Perez-Cordon, D Sanchez-Ruiz, ...
J Prev Alzheimers Dis 4 (2), 100-108, 2017
332017
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease
M Alegret, N Muñoz, N Roberto, DM Rentz, S Valero, S Gil, M Marquié, ...
Alzheimer's research & therapy 12, 1-11, 2020
322020
Impact of recruitment methods in subjective cognitive decline
C Abdelnour, O Rodríguez-Gómez, M Alegret, S Valero, S Moreno-Grau, ...
Journal of Alzheimer's Disease 57 (2), 625-632, 2017
322017
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ...
Alzheimer's research & therapy 12, 1-14, 2020
312020
Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ...
Alzheimer's research & therapy 12, 1-14, 2020
312020
Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic
D Sánchez, M Castilla-Marti, M Marquié, S Valero, S Moreno-Grau, ...
Scientific reports 10 (1), 1580, 2020
292020
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
S Valero, M Marquié, I De Rojas, A Espinosa, S Moreno-Grau, A Orellana, ...
Scientific Reports 10 (1), 20058, 2020
18*2020
From face-to-face to home-to-home: Validity of a Teleneuropsychological battery
M Alegret, A Espinosa, G Ortega, A Pérez-Cordón, Á Sanabria, ...
Journal of Alzheimer's Disease 81 (4), 1541-1553, 2021
132021
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
X Morató, M Marquié, JP Tartari, A Lafuente, C Abdelnour, M Alegret, ...
Scientific Reports 13 (1), 5406, 2023
102023
The system can't perform the operation now. Try again later.
Articles 1–20